IPCA Laboratories submits board meeting intimation

22 Jan 2024 Evaluate
Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IPCA Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 14th February, 2024, to consider and take on record the Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December, 2023. Further, with reference to the above meeting of the Board of Directors, they have already informed vide its letter dated 21st December, 2023 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with immediate effect and until 48 hours after the declaration of the Company’s unaudited financial results for the 3rd quarter and nine months ended 31st December, 2023 of the financial year 2023-24, i.e., till 16th February, 2024.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1340.00 3.90 (0.29%)
06-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.